Annual Accounts Payable
$11.56 M
+$6.96 M+151.09%
31 December 2023
Summary:
Xeris Biopharma Holdings annual accounts payable is currently $11.56 million, with the most recent change of +$6.96 million (+151.09%) on 31 December 2023. During the last 3 years, it has risen by +$8.45 million (+271.03%). XERS annual accounts payable is now at all-time high.XERS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$7.45 M
+$1.65 M+28.51%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly accounts payable is currently $7.45 million, with the most recent change of +$1.65 million (+28.51%) on 30 September 2024. Over the past year, it has dropped by -$4.63 million (-38.31%). XERS quarterly accounts payable is now -38.31% below its all-time high of $12.08 million, reached on 30 September 2023.XERS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +151.1% | -38.3% |
| 3 y3 years | +271.0% | +73.7% |
| 5 y5 years | +1235.5% | +344.0% |
XERS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +271.0% | -38.3% | +90.3% |
| 5 y | 5 years | at high | +1235.5% | -38.3% | +344.0% |
| alltime | all time | at high | +1235.5% | -38.3% | +1240.1% |
Xeris Biopharma Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.45 M(+28.5%) |
| June 2024 | - | $5.80 M(-18.3%) |
| Mar 2024 | - | $7.09 M(-38.7%) |
| Dec 2023 | $11.56 M(+151.1%) | $11.56 M(-4.2%) |
| Sept 2023 | - | $12.08 M(+3.9%) |
| June 2023 | - | $11.62 M(-3.0%) |
| Mar 2023 | - | $11.98 M(+160.2%) |
| Dec 2022 | $4.61 M(-48.4%) | $4.61 M(+17.6%) |
| Sept 2022 | - | $3.92 M(-40.9%) |
| June 2022 | - | $6.63 M(-40.2%) |
| Mar 2022 | - | $11.09 M(+24.3%) |
| Dec 2021 | $8.92 M | $8.92 M(+108.0%) |
| Sept 2021 | - | $4.29 M(-17.3%) |
| June 2021 | - | $5.18 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $4.77 M(+53.0%) |
| Dec 2020 | $3.12 M(-44.4%) | $3.12 M(-33.6%) |
| Sept 2020 | - | $4.69 M(+5.7%) |
| June 2020 | - | $4.44 M(+15.6%) |
| Mar 2020 | - | $3.84 M(-31.5%) |
| Dec 2019 | $5.60 M(+547.0%) | $5.60 M(+233.9%) |
| Sept 2019 | - | $1.68 M(-8.8%) |
| June 2019 | - | $1.84 M(+30.7%) |
| Mar 2019 | - | $1.41 M(+62.6%) |
| Dec 2018 | $866.00 K(-56.2%) | $866.00 K(+39.2%) |
| Sept 2018 | - | $622.00 K(+11.9%) |
| June 2018 | - | $556.00 K(-34.4%) |
| Mar 2018 | - | $847.00 K(-57.1%) |
| Dec 2017 | $1.98 M(+50.3%) | $1.98 M |
| Dec 2016 | $1.31 M | - |
FAQ
- What is Xeris Biopharma Holdings annual accounts payable?
- What is the all time high annual accounts payable for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual accounts payable year-on-year change?
- What is Xeris Biopharma Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly accounts payable year-on-year change?
What is Xeris Biopharma Holdings annual accounts payable?
The current annual accounts payable of XERS is $11.56 M
What is the all time high annual accounts payable for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual accounts payable is $11.56 M
What is Xeris Biopharma Holdings annual accounts payable year-on-year change?
Over the past year, XERS annual accounts payable has changed by +$6.96 M (+151.09%)
What is Xeris Biopharma Holdings quarterly accounts payable?
The current quarterly accounts payable of XERS is $7.45 M
What is the all time high quarterly accounts payable for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly accounts payable is $12.08 M
What is Xeris Biopharma Holdings quarterly accounts payable year-on-year change?
Over the past year, XERS quarterly accounts payable has changed by -$4.63 M (-38.31%)